FDA Approved: AMMONIA N 13 — Original Application (Ionetix Corporation)

View source ↗

Summary

The FDA approved Ammonia N-13 from Ionetix Corporation under the Original Application, enabling its use as a radiopharmaceutical for PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• AMMONIA N 13 (NH3N13)

Snippet

ORIG AP for AMMONIA N 13 (AMMONIA N-13)